Agilent Technologies’ Application Kits for Pesticides and Toxicology Analysis Provide Fast Track to More Productivity in Lab

SANTA CLARA, Calif.--Agilent Technologies Inc. (NYSE:A - News) today announced the availability of pesticides and toxicology application kits to improve workflow and productivity in food, environmental and forensic markets. During the past four decades Agilent has taken an active role in developing methods that have evolved into global industry standards. More than 60 quick-start application [...]

Pacific Biosciences Names Dr. Eric Schadt Chief Scientific Officer

MENLO PARK, Calif.--Pacific Biosciences, a private company developing third-generation DNA sequencing technology, today announced that leading genetic scientist Eric E. Schadt, Ph.D. has joined the company as Chief Scientific Officer. Dr. Schadt joins Pacific Biosciences from Rosetta Inpharmatics, a subsidiary of Merck & Co., Inc. in Seattle, where he was Executive Scientific Director of Genetics. [...]

Agilent Technologies’ Enterprise Content Management System Now Supports Dionex Chromeleon Chromatography Software

SANTA CLARA, Calif., May 28, 2009 Agilent Technologies Inc. (NYSE: A) today announced that its OpenLAB Enterprise Content Management (ECM) system now supports the archiving of data generated by Dionex Corp.'s Chromeleon 6.8 chromatography software. This demonstrates Agilent's continued commitment to open systems, resulting in broader customer choice. "Chromatography software such as Chromeleon stores data [...]

Clontech Laboratories, Inc. Releases the Xfect(TM) and Xfect(TM) Stem Transfection Reagents

MOUNTAIN VIEW, Calif., May 28 -- Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the upcoming (June 1, 2009) release of the Xfect(TM) and Xfect(TM) Stem transfection reagents. These novel transfection reagents are based on biodegradable nanoparticles that permit superior transfection efficiency of plasmid DNA into mammalian cells. For added ease [...]

BioTrove Launches RapidFire 300 for in vitro ADME Discovery

WOBURN, Mass.--BioTrove, Inc. today announced the launch of its RapidFire® 300 system for high-throughput screening of in vitro ADME assays. Producing label-free data at six to eight seconds per sample, drug discovery researchers can now use the high-throughput, mass spectrometry based method to analyze in vitro ADME assays in a fraction of the time required [...]

Cancer Research UK Purchases Fluidigm Genotyping System…

Fluidigm Europe has announced that the Cancer Research UK Centre for Genetic Epidemiology, University of Cambridge, based at Strangeways Research Laboratory, has purchased the company's EP1 System to conduct cancer research and disease association studies. The Fluidigm EP1 system combines the efficiencies of integrated fluidic circuit (IFC)-based high-throughput genotyping in a desktop-sized configuration, with a [...]

Genome Institute of Singapore and Roche NimbleGen: Tracking the Evolutionary Path of the novel H1N1 Influenza A

MADISON, Wis.--The recent outbreak of the flu virus, the new strain of Influenza A (nH1N1), has rapidly spread around the world. Many experts are concerned for the evolutionary track of this new strain and whether it will mutate or re-assort with other influenza strains to potentially produce a more deadly strain, as the world experienced [...]

1st Detect Awarded SBIR from the Defense Threat Reduction Agency

Project to Develop a Pre-Concentrator for Miniature Mass Spectrometer AUSTIN, Texas--1st Detect Corporation, a subsidiary of Astrotech Corporation (Nasdaq:ASTC), announced today it is the recipient of a Phase I award from the U.S. Army’s Chemical and Biological Defense (CBD) Small Business Innovation Research (SBIR) Program. The award will go to the development of a novel [...]

Caprion Proteomics Inc. and Applied Bioystems Work Together to Accelerate Protein Biomarker Verification and Validation

Combination of industry-leading services with unique QTRAP(R) technology MONTREAL, May 28 -- Caprion Proteomics Inc. today announced that it is working with Applied Biosystems, a division of Life Technologies Corporation (NASDAQ: LIFE) , to accelerate the verification and validation of protein biomarker candidates toward potential use in clinical settings. Caprion is extending its leadership in [...]

Bruker and Carl Zeiss Announce Collaboration to Advance Molecular Histology

Integration of MIRAX Virtual Slide Scanner from Carl Zeiss into Bruker's MALDI Molecular Imager(TM) Enables Non-Targeted Molecular Histology -- Combined Solution to be Introduced at German Pathology Society (DGP) Meeting in June 2009 BREMEN, Germany & JENA, Germany, May 28, 2009 -- Bruker Daltonik GmbH and Carl Zeiss MicroImaging GmbH today announced the integration of [...]

Access IBO on Knowledge Center